Clinical Trials Directory

Trials / Conditions / Vaso-occlusive Pain Episode in Sickle Cell Disease

Vaso-occlusive Pain Episode in Sickle Cell Disease

9 registered clinical trials studyying Vaso-occlusive Pain Episode in Sickle Cell Disease — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingSub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
NCT07369024
Mohsen SaidinejadPhase 2
Not Yet RecruitingLidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
NCT07274254
Nantes University HospitalPhase 3
RecruitingClinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
NCT06665997
University of PennsylvaniaPhase 4
RecruitingVirtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Oc
NCT06184126
University of Maryland, BaltimoreN/A
UnknownClonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease P
NCT05848531
Centre Hospitalier Universitaire Saint PierrePhase 4
TerminatedA Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
NCT05348915
PfizerPhase 3
TerminatedA Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Rec
NCT04927247
PfizerPhase 3
CompletedA Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing
NCT04935879
PfizerPhase 3
TerminatedIntranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in
NCT04150757
Abigail NixonPhase 3